Windtree Therapeutics, Inc. Common Stock

Go to Windtree Therapeutics, Inc. Common Stock Website

$0.60

0.02 (3.01%)
Live
Previous Close

$0.5818

Day Range

$0 - $0

Previous Day Range

$0.5603 - $0.6527

Market Cap

$7.1 million USD

Day Vol.

0

Previous Day Vol.

3.4 million

Currency

USD

Primary Exchange

Nasdaq

Windtree Therapeutics Inc is a biotechnology company focused on advancing early and late-stage therapies for critical conditions and diseases. Its portfolio of product candidates includes istaroxime, a Phase 2 candidate with sarco endoplasmic reticul...


Community
  • 0 posts discussing
0

Watchers

0

Visitors


Recent News

Windtree Therapeutics secures up to $520 million in funding through an equity line of credit and stock purchase agreement, with 99% of proceeds dedicated to acquiring BNB cryptocurrency as part of its innovative treasury strategy.

Related tickers: WINT.

Read Full Article

Evofem Biosciences has entered into an agreement with Windtree Therapeutics to reduce the manufacturing cost of its contraceptive product PHEXXI by 55-60%. This will allow Evofem to expand PHEXXI's global availability, particularly in price-sensitive markets.

Related tickers: EVFM, WINT.

Read Full Article
Trending Tickers

Please sign in to view